Delivery Order SPE2DB22D3011-SPE2DB25FQ2SU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,058.66. This competitive award, which utilizes firm fixed price pricing, represents a non-set-aside contract and is scheduled for completion by August 29, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,129.71. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was awarded without set-aside provisions through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.98 for 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg on September 8, 2025, with completion scheduled for September 9, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is being performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a $3,106.29 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Pantoprazole Sodium delayed-release 40 milligram tablets in a quantity of 1,000 units. This is a firm fixed-price contract with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a 90-count package. This order, valued at $1,120.33, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The award is non-set-aside and was...
- The Defense Logistics Agency awarded a delivery order valued at $2,871.12 to AmerisourceBergen Drug Corp for Pantoprazole Sodium Delayed-Release 40 mg tablets (90-count supply). This competitively awarded, non-set-aside contract carries a firm fixed price and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The work is to be completed by August 21, 2025, with performance occurring at the contractor's facility in Conshohocken,...
- This delivery order, awarded on July 23, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg under a firm fixed-price contract valued at $5,474.50. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. This IDC enables...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,187,922 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The firm fixed-price contract, valued at $2,008.44, has an ultimate completion date of October 24, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization, is the prime contractor with no major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,015.70 to AmerisourceBergen Drug Corp for 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg, with a completion date of September 15, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award based on the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of performance is AmerisourceBergen's corporate office...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2SUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,089.14. This is a firm fixed-price, non-set-aside contract with performance completion scheduled for September 15, 2025, and fulfillment to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected for this award based on its established capability to supply critical medical commodities to federal military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains through its prime IDC with DLA, which enables flexible fulfillment of federal medical procurement needs for organizations including the Defense Health Agency and U.S. Coast Guard. This pantoprazole order reflects the company's ongoing role in supporting gastrointestinal pharmaceutical requirements within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/12/25 |